SCHEMBL30936749

SCHEMBL30936749

O=C(O)CCCCCCC=CCCCCCCCC1CO1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 4/20 0.53
PPARD Q03181 4/20 0.53
PPARA Q07869 4/20 0.53
MAPT P10636 4/20 0.53
F7 P08709 4/20 0.53
F3 P13726 4/20 0.53
TERT O14746 3/20 0.53
PTPN1 P18031 3/20 0.53
BLM P54132 3/20 0.53
HSD17B10 Q99714 3/20 0.53
FABP4 P15090 2/20 0.53
LMNA P02545 2/20 0.53
ALOX15 P16050 2/20 0.53
RECQL P46063 2/20 0.53
DUSP3 P51452 2/20 0.53
CYP19A1 P11511 2/20 0.53
PTGS1 P23219 2/20 0.53
KMT2A Q03164 2/20 0.53
PTPN7 P35236 2/20 0.53
TDP1 Q9NUW8 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31050901 0.97 TOP1 (0.51) PPARGPPARDPPARAMAPTF7
SCHEMBL5184107 0.89 TSHR (0.52) PPARGPPARDPPARAPTPN1BLM
SCHEMBL3681566 0.89 TSHR (0.52) PPARGPPARDPPARAPTPN1BLM
SCHEMBL2211224 0.89 TSHR (0.52) PPARGPPARDPPARAPTPN1BLM
SCHEMBL16330820 0.89 TSHR (0.52) PPARGPPARDPPARAPTPN1BLM
SCHEMBL28510669 0.89 TSHR (0.52) PPARGPPARDPPARAPTPN1BLM
SCHEMBL6829630 0.87 LMNA (0.50) PPARGPPARDPPARABLMHSD17B10
SCHEMBL1176738 0.87 LMNA (0.50) PPARGPPARDPPARABLMHSD17B10
Arachidonic Acid SCHEMBL27532997 0.85 ALDH1A1 (0.68) PPARGPPARDPPARAMAPTF7
SCHEMBL27033147 0.81 PPARG (0.51) PPARGPPARDPPARAMAPTF7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118534010-A Application of metabolic markers in preparation of diabetic retinopathy diagnosis or prognosis products 海南医学院 2024-08-23 CN claimed
CN-118376772-A Method for evaluating drug-regulated metabolic pathway based on lipometabonomics analysis 海南医学院 2024-07-23 CN claimed
WO-2025038374-A1 METHODS OF IMPROVING MICROVASCULAR HEALTH MARS, INCORPORATED (US) 2025-02-20 WO disclosed
CN-118534010-A Application of metabolic markers in preparation of diabetic retinopathy diagnosis or prognosis products 海南医学院 2024-08-23 CN disclosed
CN-118534010-A Application of metabolic markers in preparation of diabetic retinopathy diagnosis or prognosis products 海南医学院 2024-08-23 CN disclosed
CN-118376772-A Method for evaluating drug-regulated metabolic pathway based on lipometabonomics analysis 海南医学院 2024-07-23 CN disclosed
CN-118376790-A Diagnostic marker composition for assisting in predicting acupoint catgut implantation and improving drug-withdrawal effect 长春中医药大学 2024-07-23 CN disclosed
CN-118243934-A Use of serum markers for the preparation of products for diagnosis/prognosis of rheumatoid arthritis 海南医学院 2024-06-25 CN disclosed